DNA-Mediated Self-Assembled SERS Platform Combined with Machine Learning for Therapeutic Drug Monitoring
Analytical Chemistry · 10.11.2026 · 98 (44) · 31550-31561
DOI: 10.1021/acs.analchem.6c05327 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 19.10.2026. Verfasst von Ruiyao Ma und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), College of Pharmacy, Harbin Medical University, Harbin150081, Heilongjiang, PR…. Hauptthemen laut MEDLINE: Spectrum Analysis, Raman, DNA, Drug Monitoring, Machine Learning. Die Arbeit nennt 24 Literaturangaben. Gefördert von: Natural Science Foundation of Heilongjiang Province.
Abstract (Originalsprache)
Therapeutic drug monitoring (TDM) critically requires rapid, sensitive, and practical methods for personalized medicine. Herein, we present a label-free surface-enhanced Raman spectroscopy (SERS) platform based on self-assembly of T12 DNA on Ag@ITCNPs mediated by Ca2+. This substrate generates abundant electromagnetic hotspots via electrostatic crosslinking and utilizes the intrinsic thymine peak as an internal standard to effectively eliminate serum matrix interference, achieving an analytical enhancement factor (AEF) of 5.93 × 1013. The platform enables ultrasensitive detection of various antiepileptics and immunosuppressants (e.g., cyclosporine A, carbamazepine, valproate) at the fg/mL level, with excellent reproducibility (RSD = 4.10%). By integrating unsupervised algorithms (PCA, t-SNE) and supervised models (CNN, SVM, KNN, LDA, RF, RNN, XGBoost), it achieves near 100% accuracy in discriminating between different drugs and even among individual patients receiving the same medication. Furthermore, regression models based on SERS enable precise quantification, with results showing excellent agreement with the LC−MS/MS gold standard. This work demonstrates that the synergy between self-assembly directed by DNA and machine learning provides a powerful strategy for constructing highly sensitive and selective SERS platforms, offering a promising solution for rapid therapeutic drug monitoring at the point of care in complex biological matrices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), College of Pharmacy, Harbin Medical University, Harbin150081, Heilongjiang, PR. China.
- State Key Laboratory of High-Performance Ceramics, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai200050, China.
- Department of Pharmacy at The Second Affiliated Hospital, and Department of Pharmacology at College of Pharmacy (The Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), Harbin Medical University,…
- Department of Respiratory Medicine, The Second Hospital of Jilin University, Changchun130022, Jilin, PR. China.
- Research Unit of Health Sciences and Technology (HST), Faculty of Medicine University of Oulu, Oulu90570, Finland.
- Inpatient Department, Heilongjiang Provincial Eye Hospital, Harbin150081, Heilongjiang, China.
ORCID-Profile: Yang Li
Förderung
- Natural Science Foundation of Heilongjiang Province
Zitieren
APA
Ma, R., Li, D., Ji, H., Xing, Y., Liu, Q., Sun, Z., Huang, Y., Xia, L., Jiang, S., Hu, X., Guo, L., & Li, Y. (2026). DNA-Mediated Self-Assembled SERS Platform Combined with Machine Learning for Therapeutic Drug Monitoring. Analytical Chemistry, 98(44), 31550-31561. https://doi.org/10.1021/acs.analchem.6c05327
Vancouver
Ma R, Li D, Ji H, Xing Y, Liu Q, Sun Z, et al. DNA-Mediated Self-Assembled SERS Platform Combined with Machine Learning for Therapeutic Drug Monitoring. Analytical Chemistry. 2026;98(44):31550-31561. doi:10.1021/acs.analchem.6c05327
BibTeX
@article{Ma2026,
author = {Ma, Ruiyao and Li, Dan and Ji, Haoyu and Xing, Yaowen and Liu, Qiushuang and Sun, Zhidan and Huang, Yujiang and Xia, Ling and Jiang, Shen and Hu, Xinyue and Guo, Lixin and Li, Yang},
title = {DNA-Mediated Self-Assembled SERS Platform Combined with Machine Learning for Therapeutic Drug Monitoring},
journal = {Analytical Chemistry},
year = {2026},
volume = {98},
number = {44},
pages = {31550--31561},
doi = {10.1021/acs.analchem.6c05327}
}
EUVIMED